Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liwen Liang

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 10, 2023
Anti-CXCR2 antibody-coated nanoparticles with an erythrocyte-platelet hybrid membrane layer for atherosclerosis therapyRongzhong Huang, Lujun Zhang, Xingsheng Li, et al.
The Canadian Journal of Cardiology|June 3, 2020
Cardiac Rehabilitation Programs for Chronic Heart Disease: A Bayesian Network Meta-analysisRongzhong Huang, Suetonia C Palmer, Yu Cao, et al.
Translational Pediatrics|July 8, 2022
Prevalence and risk factors for congenital heart defects among children in the Multi-Ethnic Yunnan Region of ChinaYu Cao, Rongzhong Huang, Ruize Kong, et al.
Journal of Thrombosis and Haemostasis : JTH|March 9, 2023
Stroke-induced hexokinase 2 in circulating monocytes exacerbates vascular inflammation and atheroprogressionYang Sun, Lujun Zhang, Yu Cao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 11, 2021
The Transcription Factor SUB1 Is a Master Regulator of the Macrophage TLR Response in AtherosclerosisRongzhong Huang, Zicheng Hu, Xiaorui Chen, et al.
Cell Reports|December 4, 2025
Interleukin-1/Toll-like receptor signaling potentiates macrophage olfactory receptor 2-driven atherosclerosisLujun Zhang, Jili Fu, Zicheng Hu, et al.
Hepatology Communications|May 16, 2018
Elbasvir/grazoprevir in Asia-Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infectionJacob George, Eduard Burnevich, I-Shyan Sheen, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 10, 2023
Anti-CXCR2 antibody-coated nanoparticles with an erythrocyte-platelet hybrid membrane layer for atherosclerosis therapyRongzhong Huang, Lujun Zhang, Xingsheng Li, et al.
The Canadian Journal of Cardiology|June 3, 2020
Cardiac Rehabilitation Programs for Chronic Heart Disease: A Bayesian Network Meta-analysisRongzhong Huang, Suetonia C Palmer, Yu Cao, et al.
Translational Pediatrics|July 8, 2022
Prevalence and risk factors for congenital heart defects among children in the Multi-Ethnic Yunnan Region of ChinaYu Cao, Rongzhong Huang, Ruize Kong, et al.
Journal of Thrombosis and Haemostasis : JTH|March 9, 2023
Stroke-induced hexokinase 2 in circulating monocytes exacerbates vascular inflammation and atheroprogressionYang Sun, Lujun Zhang, Yu Cao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 11, 2021
The Transcription Factor SUB1 Is a Master Regulator of the Macrophage TLR Response in AtherosclerosisRongzhong Huang, Zicheng Hu, Xiaorui Chen, et al.
Cell Reports|December 4, 2025
Interleukin-1/Toll-like receptor signaling potentiates macrophage olfactory receptor 2-driven atherosclerosisLujun Zhang, Jili Fu, Zicheng Hu, et al.
Hepatology Communications|May 16, 2018
Elbasvir/grazoprevir in Asia-Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infectionJacob George, Eduard Burnevich, I-Shyan Sheen, et al.
Pageof 5